Global CRO footprint Excelya operates in 28 countries across Europe, the USA and India with a global team of over 900+ experts, indicating potential for multinational clinical programs and cross-border trial support that can be offered to large pharma clients seeking scalable CRO partnerships.

Therapeutic Focus Strong specialization in Oncology & Hematology, Rare Disease & Pediatrics, Infectious Disease, Inflammation & Immunotherapy, and CNS/ Pain, suggesting upsell opportunities in high-value therapeutic areas for full-service CRO, FSP, and resourcing solutions.

Sustainability Cred EcoVadis Bronze Medal (and top 35% recognition) demonstrates a commitment to sustainable and responsible business practices, which can be leveraged to win business with ESG-conscious sponsors and to differentiate from competitors.

Tech Enabled Adoption of industry tools such as Veeva Systems, Oracle Clinical, and MySQL indicates solid data and clinical trial management capabilities, enabling conversations about digital efficiency, data integrity, and streamlined study delivery to potential clients.

Growth Signals Leadership updates and steady expansion since 2014, including notable CFO and operations hires, plus a history of partnerships (e.g., Zeincro) point to a growth trajectory and potential for increased capacity, new service lines, and larger client engagements.